This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Are Scooping Up

CVS Caremark

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

A stock in the retail drug complex whos insiders are buying up a large amount of stock in is CVS Caremark (CVS), a pharmacy healthcare provider in the U.S. Insiders are buying into some mild strength here since this stock is up over 9.4% in 2012.

CVS Caremark has a market cap of $57 billion and an enterprise value of $66 billion. This stocks trades at a cheap valuation, with a trailing price-to-earnings of 17 and a forward price-to-earnings of 12. Its estimated growth rate for this year is 16.8%, and for next year it's pegged at 12.5%. This is not a cash-rich company, since the total cash position on its balance sheet is $1.42 billion and its total debt is a whopping $10.01 billion.

A vice president just bought 46,400 shares, or about $1.99 million worth of stock, at $42.99 per share.

From a technical perspective, CVS is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock broke out above $39.15 to $39.26 a share a few months ago on huge volume. Since triggering that breakout, this stock has uptrended strong towards its current price of $44.50 a share.

If you're a bullish on CVS, then I would look for long biased trades as long as this stock is trending above $44 a share, and the upside volume is tracking in strong. If this stock were to trade back below $44, then I would look for long setups near the 200-day moving average of $42.97 or the 50-day moving average of $41.36 a share. I would avoid any long trades in CVS if the 50-day and 200-day were violated with big volume.

CVS, one of Warren Buffett's holdings, shows up on lists of 8 UBS Stock Picks for 2012 and 3 Health Care Buys for 2012.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,987.51 -61.49 -0.36%
S&P 500 1,985.54 -11.91 -0.60%
NASDAQ 4,567.5980 -24.2080 -0.53%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs